Cerebral metabolic alterations during cardiac arrest, cardiopulmonary resuscitation (CPR) and extracorporeal cardiopulmonary life support (ECLS) are poorly explored. Markers are needed for a more pers
L-NAME can obviously restrain the vasorelaxation of SFI (A) and HSI (B). **P<0.01 vs Control (the control group was added an equal volume K-H solution); #P<0.05, ##P<0.01 vs SFI or HSI.
Revisión de la literatura sobre el uso de los vasoactivos en el paciente crítico para una conferencia en el I Congreso de Toxicología y Farmacología Clínica de la Universidad Cooperativa de Colombia,
